Non-Invasive Brain Therapy for Modern Neurological Care
Transcranial stimulation involves the application of electrical currents or magnetic fields to modulate brain activity non-invasively. This innovative technology, such as the STORZ MEDICAL NEUROLITH SD1, offers promising therapeutic applications in neurology. These devices can be utilized for conditions like chronic pain management, stroke rehabilitation, and neurological disorders, providing a safe and effective alternative for patients seeking advanced treatment options. SWT Orthopaedics is proud to offer the NEUROLITH SD1, empowering healthcare professionals with cutting-edge tools to optimize neurology care and outcomes.
NEUROLITH SD1
SWT Therapy Group proudly introduces the STORZ MEDICAL NEUROLITH® TPS system — an advanced Transcranial Pulse Stimulation (TPS) technology developed by STORZ Medical of Switzerland. This innovative non-invasive platform delivers ultrashort acoustic pulses at ultrasound frequencies, enabling highly focused brain stimulation up to approximately 8 cm deep with exceptional precision and safety.
Neurolith is recognized globally as the world’s first clinically validated complete acoustic transcranial stimulation system for neurological applications. The system integrates a sophisticated TPS handpiece, real-time stimulation visualization software (BodyTrack®), MRI-based neuronavigation for individualized treatment targeting, precise treatment documentation, and advanced patient database capabilities.
Since its introduction, Neurolith adoption has expanded rapidly worldwide, with the technology now utilized in more than 230 clinics and neurological centers across over 47 countries. Globally, an estimated 10,000–15,000+ patients have undergone treatment, with more than 110,000–150,000+ TPS sessions performed to date.
Neurolith TPS is primarily utilized in cognitive and neurological care programs involving Alzheimer’s disease and dementia, with expanding global interest in additional neurological and neurorehabilitation applications. Clinics and physicians worldwide have reported encouraging patient outcomes including improvements in memory recall, attention, communication, alertness, mood, social engagement, and daily functional performance, particularly in mild-to-moderate cognitive decline.
The Neurolith platform also continues to attract significant international research interest in areas including Parkinson’s disease, stroke rehabilitation, traumatic brain injury, depression, Long COVID cognitive dysfunction, autism spectrum research, and other neurological conditions.
If you would like to explore how Neurolith TPS can enhance your neurological or cognitive treatment programs, please contact SWT Therapy Group. Our experienced clinical and technical team provides comprehensive guidance, training, and ongoing support tailored to your practice and patient population.
Learn More
